Formulation and characterization of inhalable magnetic nanocomposite microparticles (MnMs) for targeted pulmonary delivery via spray drying

International Journal of Pharmaceutics

Volumn 479, Issue 2, 2015, Pages 320-328

  Stocke, Nathanael A ^a   Meenach, Samantha A ^a,b   Arnold, Susanne M ^c   Mansour, Heidi M ^b   Hilt, J Zach ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b University of Kentucky   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Dry powder inhalation aerosols; Iron oxide; Magnetic nanoparticles; Nanocomposites; Remote heating; Spray drying

Indexed keywords

IRON OXIDE; MAGNETIC NANOCOMPOSITE MICROPARTICLE; MAGNETIC NANOPARTICLE; MANNITOL; NANOCARRIER; UNCLASSIFIED DRUG; AEROSOL; DRUG CARRIER; MAGNETITE NANOPARTICLE; NANOCOMPOSITE; POWDER;

ABSORPTION; AEROSOL; ARTICLE; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG SYNTHESIS; DRY POWDER INHALER; HEATING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; LUNG CANCER CELL LINE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SPRAY DRYING; THERMOGRAVIMETRY; WATER CONTENT; X RAY POWDER DIFFRACTION; CELL LINE; CHEMISTRY; DRUG DELIVERY SYSTEM; LUNG; MAGNETIC FIELD; MEDICINAL CHEMISTRY; METABOLISM; PARTICLE SIZE; POWDER; PROCEDURES;

AEROSOLS; CELL LINE; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; HUMANS; LUNG; MAGNETIC FIELDS; MAGNETITE NANOPARTICLES; MANNITOL; NANOCOMPOSITES; PARTICLE SIZE; POWDERS;

EID: 84920997238     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.12.050     Document Type: Article

References (50)

1. USP 29-NF 24, 2006. Aerosols, Nasal Sprays, Metered-Dose Inhalers, and Dry Powder Inhalers Monograph, in: USP 29-NF 24 The United States Pharmacopoeia and The National Formulary: The Official Compendia of Standards The United States Pharmacopeial Convention, Inc., Rockville, MD, pp. 2617-2636.
2. S. Azarmi, W.H. Roa, and R. Loebenberg Targeted delivery of nanoparticles for the treatment of lung diseases Adv. Drug Deliv. Rev. 60 2008 863 875
3. A. Burger, J.O. Henck, S. Hetz, J.M. Rollinger, A.A. Weissnicht, and H. Stottner Energy/temperature diagram and compression behavior of the polymorphs of d-mannitol J. Pharm. Sci. 89 2000 457 468
4. J.F. Carpenter, M.J. Pikal, B.S. Chang, and T.W. Randolph Rational design of stable lyophilized protein formulations: some practical advice Pharm. Res. 14 1997 969 975
5. A.H.L. Chow, H.H.Y. Tong, P. Chattopadhyay, and B.Y. Shekunov Particle engineering for pulmonary drug delivery Pharm. Res. 24 2007 411 437
6. P. Dames, B. Gleich, A. Flemmer, K. Hajek, N. Seidl, F. Wiekhorst, D. Eberbeck, I. Bittmann, C. Bergemann, T. Weyh, L. Trahms, J. Rosenecker, and C. Rudolph Targeted delivery of magnetic aerosol droplets to the lung Nat. Nanotech. 2 2007 495 499
7. M.B. Dolovich, R.C. Ahrens, D.R. Hess, P. Anderson, R. Dhand, J.L. Rau, G.C. Smaldone, and G. Guyatt Device selection and outcomes of aerosol therapy: evidence-based guidelines Chest 127 2005 335 371
8. Finlay, W., 2008. The ARLA Respiratory Deposition Calculator, in, 2008.
9. R.A. Frimpong, and J.Z. Hilt Magnetic nanoparticles in biomedicine: synthesis, functionalization and applications Nanomedicine 5 2010 1401 1414
10. F.R. Fronczek, H.N. Kamel, and M. Slattery Three polymorphs (alpha, beta and delta) of d-mannitol at 100 K Acta Crystallogr. Sect. C 59 2003 O567 O570
11. J. Gjoerup, O. Hilberg, and E. Bendstrup Inhaled mannitol in the treatment of non-cystic fibrosis bronchiectasis in adults Respirology 17 2012 927 932
12. G. Hasenpusch, J. Geiger, K. Wagner, O. Mykhaylyk, F. Wiekhorst, L. Trahms, A. Heidsieck, B. Gleich, C. Bergemann, M.K. Aneja, and C. Rudolph Magnetized aerosols comprising superparamagnetic iron oxide nanoparticles improve targeted drug and gene delivery to the lung Pharm. Res. 29 2012 1308 1318
13. A.M. Hawkins, N.S. Satarkar, and J.Z. Hilt Nanocomposite degradable hydrogels: demonstration of remote controlled degradation and drug release Pharm. Res. 26 2009 667 673
14. M.R. Horsman, and J. Overgaard Hyperthermia: a potent enhancer of radiotherapy Clin. Oncol. 19 2007 418 426
15. R.D. Issels Hyperthermia adds to chemotherapy Eur. J. Cancer 44 2008 2546 2554
16. M. Johannsen, B. Thiesen, P. Wust, and A. Jordan Magnetic nanoparticle hyperthermia for prostate cancer Int. J. Hyperthermia 26 2010 790 795
17. A. Jordan, R. Scholz, P. Wust, H. Fahling, and R. Felix Magnetic fluid hyperthermia (MFH): cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles J. Magn. Magn. Mater. 201 1999 413 419
18. A. Jordan, R. Scholz, K. Maier-Hauff, M. Johannsen, P. Wust, J. Nadobny, H. Schirra, H. Schmidt, S. Deger, S. Loening, W. Lanksch, and R. Felix Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia J. Magn. Magn. Mater. 225 2001 118 126
19. A. Jordan, R. Scholz, K. Maier-Hauff, F.K.H. van Landeghem, N. Waldoefner, U. Teichgraeber, J. Pinkernelle, H. Bruhn, F. Neumann, B. Thiesen, A. von Deimling, and R. Felix The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma J. Neuro-oncol. 78 2006 7 14
20. L.D. Knecht, N. Ali, Y.N. Wei, J.Z. Hilt, and S. Daunert Nanoparticle-mediated remote control of enzymatic activity ACS Nano 6 2012 9079 9086
21. J.T. Kwon, D.S. Kim, A. Minai-Tehrani, S.K. Hwang, S.H. Chang, E.S. Lee, C.X. Xu, H.T. Lim, J.E. Kim, B.I. Yoon, G.H. An, K.H. Lee, J.K. Lee, and M.H. Cho Inhaled fluorescent magnetic nanoparticles induced extramedullary hematopoiesis in the spleen of mice J. Occup. Health 51 2009 423 431
22. X.J. Li, and H.M. Mansour Physicochemical characterization and water vapor sorption of organic solution advanced spray-dried inhalable trehalose microparticles and nanoparticles for targeted dry powder pulmonary inhalation delivery AAPS PharmSciTech 12 2011 1420 1430
23. L. Li, T.L.M. ten Hagen, M. Hossann, R. Suss, G.C. van Rhoon, A.M.M. Eggermont, D. Haemmerich, and G.A. Koning Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy J. Control. Rel. 168 2013 142 150
24. H.M. Mansour, Y.S. Rhee, and X.A. Wu Nanomedicine in pulmonary delivery Int. J. Nanomedicine 4 2009 299 319
25. A.A. McBride, D.N. Price, L.R. Lamoureux, A.A. Elmaoued, J.M. Vargas, N.L. Adolphi, and P. Muttil Preparation and characterization of novel magnetic nano-in-microparticles for site-specific pulmonary drug delivery Mol. Pharm. 10 2013 3574 3581
26. S.L. McGill, C.L. Cuylear, N.L. Adolphi, M. Osinski, and H.D.C. Smyth Magnetically responsive nanoparticles for drug delivery applications using low magnetic field strengths IEEE Trans. Nanobiosci. 8 2009 33 42
27. S.A. Meenach, J.Z. Hilt, and K.W. Anderson Poly(ethylene glycol)-based magnetic hydrogel nanocomposites for hyperthermia cancer therapy Acta Biomater. 6 2010 1039 1046
28. S.A. Meenach, F.G. Vogt, K.W. Anderson, J.Z. Hilt, R.C. McGarry, and H.M. Mansour Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable DPPC and DPPC:DPPE-PEG microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols Int. J. Nanomedicine 8 2013 275 293
29. K. Nahar, S. Absar, B. Patel, and F. Ahsan Starch-coated magnetic liposomes as an inhalable carrier for accumulation of fasudil in the pulmonary vasculature Int. J. Pharm. 464 2014 185 195
30. L.M. Nolan, L. Tajber, B.F. McDonald, A.S. Barham, O.I. Corrigan, and A.M. Healy Excipient-free nanoporous microparticles of budesonide for pulmonary delivery Eur. J. Pharm. Sci. 37 2009 593 602
31. G.A. Otterson, M.A. Villalona-Calero, W. Hicks, X.L. Pan, J.A. Ellerton, S.N. Gettinger, and J.R. Murren Phase I/II study of inhaled doxorubicin combined with platinum-based therapy for advanced non-small cell lung cancer Clin. Cancer Res. 16 2010 2466 2473
32. Q.A. Pankhurst, J. Connolly, S.K. Jones, and J. Dobson Applications of magnetic nanoparticles in biomedicine J. Phys. D: Appl. Phys. 36 2003 R167 R181
33. J.S. Patton, and P.R. Byron Inhaling medicines: delivering drugs to the body through the lungs Nat. Rev. Drug Discov. 6 2007 67 74
34. M.A. Pena, Y. Daali, J. Barra, and P. Bustamante Partial solubility parameters of lactose, mannitol and saccharose using the modified extended Hansen method and evaporation light scattering detection Chem. Pharm. Bull. 48 2000 179 183
35. D.M. Ragab, and S. Rohani Cubic magnetically guided nanoaggregates for inhalable drug delivery: in vitro magnetic aerosol deposition study AAPS PharmSciTech 14 2013 977 993
36. G.E.S. Redman, A.R. Martin, P. Waszak, R.B. Thompson, P.Y. Cheung, B. Thebaud, and W.H. Finlay Pilot study of inhaled aerosols targeted via magnetic alignment of high aspect ratio particles in rabbits J. Nanomater. 2011 7
37. T. Sadhukha, T.S. Wiedmann, and J. Panyam Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy Biomaterials 34 2013 5163 5171
38. N.S. Satarkar, and J.Z. Hilt Hydrogel nanocomposites as remote-controlled biomaterials Acta Biomater. 4 2008 11 16
39. N.S. Satarkar, D. Biswal, and J.Z. Hilt Hydrogel nanocomposites: a review of applications as remote controlled biomaterials Soft Matter 6 2010 2364 2371
40. N.S. Satarkar, S.A. Meenach, K.W. Anderson, and J.Z. Hilt Remote actuation of hydrogel nanocomposites: heating analysis, modeling, and simulations AIChE J. 57 2011 852 860
41. S. Suarez, and A.J. Hickey Drug properties affecting aerosol behavior Respir. Care 45 2000 652 666
42. B. Szalay, E. Tatrai, G. Nyiro, T. Vezer, and G. Dura Potential toxic effects of iron oxide nanoparticles in in vivo and in vitro experiments J. Appl. Toxicol. 32 2012 446 453
43. F. Tewes, C. Ehrhardt, and A.M. Healy Superparamagnetic iron oxide nanoparticles (SPIONs)-loaded Trojan microparticles for targeted aerosol delivery to the lung Eur. J. Pharm. Biopharm. 86 2014 98 104
44. R. Vehring Pharmaceutical particle engineering via spray drying Pharm. Res. 25 2008 999 1022
45. N.K. Verma, K. Crosbie-Staunton, A. Satti, S. Gallagher, K.B. Ryan, T. Doody, C. McAtamney, R. MacLoughlin, P. Galvin, C.S. Burke, Y. Volkov, and Y.K. Gun'ko Magnetic core-shell nanoparticles for drug delivery by nebulization J. Nanobiotechnology 11 2013 12
46. C.C. Vernon, J.W. Hand, S.B. Field, D. Machin, J.B. Whaley, J. vanderZee, W.L.J. vanPutten, G.C. vanRhoon, J.D.P. vanDijk, D.G. Gonzalez, F.F. Liu, P. Goodman, and M. Sherar Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials Int. J. Radiat. Oncol. Biol. Phys. 35 1996 731 744
47. B.P.H. Wittgen, P.W.A. Kunst, K. van der Born, A.W. van Wijk, W. Perkins, F.G. Pilkiewicz, R. Perez-Soler, S. Nicholson, G.J. Peters, and P.E. Postmus Phase I study of aerosolized SLIT cisplatin in the treatment of patients with carcinoma of the lung Clin. Cancer Res. 13 2007 2414 2421
48. X. Wu, W. Zhang, D.J. Hayes, and H.M. Mansour Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried cyclosporine A multifunctional particles for dry powder inhalation aerosol delivery Int. J. Nanomedicine 8 2013 1 15
49. R.J. Wydra, A.M. Kruse, Y. Bae, K.W. Anderson, and J.Z. Hilt Synthesis and characterization of PEG-iron oxide core-shell composite nanoparticles for thermal therapy Mater. Sci. Eng. C: Mater. Biol. Appl. 33 2013 4660 4666
50. Y.Y. Xie, P.Y. Zeng, R.A. Siegel, T.S. Wiedmann, B.E. Hammer, and P.W. Longest Magnetic deposition of aerosols composed of aggregated superparamagnetic nanoparticles Pharm. Res. 27 2010 855 865